Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03010018 PGB2 cPLA2i 1.0 BCD110605C28 0.035 pmol/ml medium
LMFA03010018 PGB2 cPLA2i 1.0 BCD110605C30 0.035 pmol/ml medium
LMFA03010018 PGB2 cPLA2i 1.0 BCD110605C29 0.043 pmol/ml medium
LMFA03010018 PGB2 cPLA2i 20.0 BCD110605C64 0.051 pmol/ml medium
LMFA03010018 PGB2 cPLA2i 20.0 BCD110605C66 0.063 pmol/ml medium
LMFA03010018 PGB2 cPLA2i 20.0 BCD110605C65 0.033 pmol/ml medium
LMFA03010018 PGB2 PLDi 1.0 BCD110605C16 0.026 pmol/ml medium
LMFA03010018 PGB2 PLDi 1.0 BCD110605C17 0.026 pmol/ml medium
LMFA03010018 PGB2 PLDi 1.0 BCD110605C18 0.08 pmol/ml medium
LMFA03010018 PGB2 PLDi 20.0 BCD110605C54 0.017 pmol/ml medium
LMFA03010018 PGB2 PLDi 20.0 BCD110605C52 0.054 pmol/ml medium
LMFA03010018 PGB2 PLDi 20.0 BCD110605C53 0.039 pmol/ml medium
LMFA03010018 PGB2 KDO+cPLA2i 1.0 BCD110605C32 0.052 pmol/ml medium
LMFA03010018 PGB2 KDO+cPLA2i 1.0 BCD110605C31 0.024 pmol/ml medium
LMFA03010018 PGB2 KDO+cPLA2i 1.0 BCD110605C33 0.043 pmol/ml medium
LMFA03010018 PGB2 KDO+cPLA2i 20.0 BCD110605C68 0.155 pmol/ml medium
LMFA03010018 PGB2 KDO+cPLA2i 20.0 BCD110605C69 0.232 pmol/ml medium
LMFA03010018 PGB2 KDO+cPLA2i 20.0 BCD110605C67 0.188 pmol/ml medium
LMFA03010018 PGB2 KDO+PLDi 1.0 BCD110605C19 0.049 pmol/ml medium
LMFA03010018 PGB2 KDO+PLDi 1.0 BCD110605C20 0.062 pmol/ml medium
LMFA03010018 PGB2 KDO+PLDi 1.0 BCD110605C21 0.024 pmol/ml medium
LMFA03010018 PGB2 KDO+PLDi 20.0 BCD110605C56 0.212 pmol/ml medium
LMFA03010018 PGB2 KDO+PLDi 20.0 BCD110605C57 0.227 pmol/ml medium
LMFA03010018 PGB2 KDO+PLDi 20.0 BCD110605C55 0.245 pmol/ml medium
LMFA03010018 PGB2 KDO+ATP+cPLA2i 1.0 BCD110605C37 0.126 pmol/ml medium
LMFA03010018 PGB2 KDO+ATP+cPLA2i 1.0 BCD110605C38 0.122 pmol/ml medium
LMFA03010018 PGB2 KDO+ATP+cPLA2i 1.0 BCD110605C39 0.138 pmol/ml medium
LMFA03010018 PGB2 KDO+ATP+cPLA2i 20.0 BCD110605C74 0.848 pmol/ml medium
LMFA03010018 PGB2 KDO+ATP+cPLA2i 20.0 BCD110605C75 0.856 pmol/ml medium
LMFA03010018 PGB2 KDO+ATP+cPLA2i 20.0 BCD110605C73 0.766 pmol/ml medium
LMFA03010018 PGB2 KDO+ATP+PLDi 1.0 BCD110605C25 0.125 pmol/ml medium
LMFA03010018 PGB2 KDO+ATP+PLDi 1.0 BCD110605C27 0.113 pmol/ml medium
LMFA03010018 PGB2 KDO+ATP+PLDi 1.0 BCD110605C26 0.145 pmol/ml medium
LMFA03010018 PGB2 KDO+ATP+PLDi 20.0 BCD110605C61 2.54 pmol/ml medium
LMFA03010018 PGB2 KDO+ATP+PLDi 20.0 BCD110605C62 2.64 pmol/ml medium
LMFA03010018 PGB2 KDO+ATP+PLDi 20.0 BCD110605C63 1.79 pmol/ml medium
LMFA03010018 PGB2 KDO + ATP 1.0 BCD110605C15 0.119 pmol/ml medium
LMFA03010018 PGB2 KDO + ATP 1.0 BCD110605C14 0.182 pmol/ml medium
LMFA03010018 PGB2 KDO + ATP 1.0 BCD110605C13 0.134 pmol/ml medium
LMFA03010018 PGB2 KDO + ATP 20.0 BCD110605C49 3 pmol/ml medium
LMFA03010018 PGB2 KDO + ATP 20.0 BCD110605C50 3.09 pmol/ml medium
LMFA03010018 PGB2 KDO + ATP 20.0 BCD110605C51 2.94 pmol/ml medium
LMFA03010018 PGB2 KDO 1.0 BCD110605C08 0.025 pmol/ml medium
LMFA03010018 PGB2 KDO 1.0 BCD110605C07 0.091 pmol/ml medium
LMFA03010018 PGB2 KDO 1.0 BCD110605C09 0.077 pmol/ml medium
LMFA03010018 PGB2 KDO 20.0 BCD110605C45 0.22 pmol/ml medium
LMFA03010018 PGB2 KDO 20.0 BCD110605C44 0.26 pmol/ml medium
LMFA03010018 PGB2 KDO 20.0 BCD110605C43 0.245 pmol/ml medium
LMFA03010018 PGB2 C 0.0 BCD110605C03 0.173 pmol/ml medium
LMFA03010018 PGB2 C 0.0 BCD110605C01 0.113 pmol/ml medium